Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3348)
All Articles published online
|
Feb 7, 2006 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mathonnet M, Descottes B, Valleix D, Labrousse F, Denizot Y. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 2006; 12(5): 830-831 [PMID: 16521208 DOI: 10.3748/wjg.v12.i5.830] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/830.htm |
| Number | Citing Articles |
| 1 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 2 |
De-cai Yu, Jun Chen, Xi-tai Sun, Lin-yuan Zhuang, Chun-ping Jiang, Yi-tao Ding. Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-435
|
| 3 |
De-Cai Yu, Jun Chen, Yi-Tao Ding. Hypoxic and Highly Angiogenic Non-Tumor Tissues Surrounding Hepatocellular Carcinoma: The ‘Niche’ of Endothelial Progenitor Cells. International Journal of Molecular Sciences 2010; 11(8): 2901 doi: 10.3390/ijms11082901
|
| 4 |
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber, Ebtessam A. Essa, Sanaa A. El-Gizawy. Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a N-Nitrosodiethylamine-Induced Mice Model of Hepatocellular Carcinoma. Molecular Pharmaceutics 2023; 20(9): 4758 doi: 10.1021/acs.molpharmaceut.3c00542
|
| 5 |
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. Microbial Pathogenesis 2021; 161: 105231 doi: 10.1016/j.micpath.2021.105231
|
| 6 |
Christopher L. Daige, Jason F. Wiggins, Leslie Priddy, Terri Nelligan-Davis, Jane Zhao, David Brown. Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer. Molecular Cancer Therapeutics 2014; 13(10): 2352 doi: 10.1158/1535-7163.MCT-14-0209
|
| 7 |
Josef Ehling, Frank Tacke. Role of chemokine pathways in hepatobiliary cancer. Cancer Letters 2016; 379(2): 173 doi: 10.1016/j.canlet.2015.06.017
|
| 8 |
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w
|
| 9 |
Yun-Qing Qiu, Jue Zhou, Xin-Shan Kang, Lie-Ming Ding, Wei Yu, Fen-Lai Tan, Dan-Feng Deng. Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model. Scientific Reports 2014; 4(1) doi: 10.1038/srep04324
|
| 10 |
Yasser Bakr Mohamed, Ula M. Al-Jarhi, Mona Mohsen, Sarah Ahmad El Morsy. Urinary Vascular Endothelial Growth Factor (VEGF) as a Novel Marker for Early Prediction of Esophageal Varices in Patients with Chronic Liver Disease. Open Journal of Gastroenterology 2017; 7(05): 141 doi: 10.4236/ojgas.2017.75016
|
| 11 |
Stefano Ginanni Corradini, Sergio Morini, Francesca Liguori, Simone Carotti, Andrea Onetti Muda, Maria Antonella Burza, Maria Siciliano, Antonio Molinaro, Alfredo Cantafora, Ida Blotta, Manuela Merli, Pasquale Berloco, Massimo Rossi, Adolfo Francesco Attili, Eugenio Gaudio. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and α‐fetoprotein. Liver International 2009; 29(1): 103 doi: 10.1111/j.1478-3231.2008.01781.x
|
| 12 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11: 289 doi: 10.12688/f1000research.109142.1
|
| 13 |
Muriel Mathonnet, Bernard Descottes, Denis Valleix, François Labrousse, Véronique Truffinet, Yves Denizot. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(23): 3782-3783 doi: 10.3748/wjg.v12.i23.3782
|
| 14 |
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology 2014; 26(8): 871 doi: 10.1097/MEG.0000000000000131
|
| 15 |
Decai Yu, Linyuan Zhuang, Xitai Sun, Jun Chen, Yongzhong Yao, Kui Meng, Yitao Ding. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-122
|
| 16 |
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infection. Cellular & Molecular Immunology 2014; 11(1): 25 doi: 10.1038/cmi.2013.37
|
| 17 |
Richard S. Finn, Yoon-Koo Kang, Mary Mulcahy, Blase N. Polite, Ho Yeong Lim, Ian Walters, Christine Baudelet, Demetrios Manekas, Joong-Won Park. Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research 2012; 18(7): 2090 doi: 10.1158/1078-0432.CCR-11-1991
|
| 18 |
Wagdy M. Eldehna, Ghada H Al-Ansary, Tarfah Al-Warhi, Maiy Y Jaballah, Mahmoud Elaasser, Mahmoud Rashed. Identification of novel ureido benzothiophenes as dual VEGFR-2/EGFR anticancer agents. Bioorganic Chemistry 2024; 143: 107037 doi: 10.1016/j.bioorg.2023.107037
|
| 19 |
Hidenori Shiraha, Shin‐ichi Nishina, Kazuhide Yamamoto. Loss of runt‐related transcription factor 3 causes development and progression of hepatocellular carcinoma. Journal of Cellular Biochemistry 2011; 112(3): 745 doi: 10.1002/jcb.22973
|
| 20 |
Shakir Saleem, Imran Kazmi, Aftab Ahmad, Mohammed F. Abuzinadah, Ali Samkari, Huda M. Alkrathy, Ruqaiyah Khan. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. Nutrition and Cancer 2020; 72(1): 170 doi: 10.1080/01635581.2019.1614199
|
| 21 |
Satoshi Kuboki, Hiroaki Shimizu, Noboru Mitsuhashi, Kimihiko Kusashio, Fumio Kimura, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Masaru Miyazaki. Angiopoietin‐2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(7pt2) doi: 10.1111/j.1440-1746.2007.05175.x
|
| 22 |
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics 2016; 71(11): 639 doi: 10.6061/clinics/2016(11)04
|
| 23 |
|
| 24 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11: 289 doi: 10.12688/f1000research.109142.2
|
| 25 |
Ghada M. Salum, Noha G. Bader El Din, Marwa K. Ibrahim, Mohamed A. Anany, Reham M. Dawood, Ahmed Khairy, Mostafa K. El Awady. Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker. Journal of Interferon & Cytokine Research 2017; 37(7): 310 doi: 10.1089/jir.2016.0127
|
| 26 |
Andry Irawan, Erik Prabowo, Ignatius Riwanto, Wahyuni Lukita Atmodjo. Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats. F1000Research 2022; 11: 289 doi: 10.12688/f1000research.109142.3
|